The role of elastography in non-alcoholic fatty liver disease

被引：9

作者：

Liguori, Antonio ^{[1
]}

Ainora, Maria E. ^{[1
]}

Riccardi, Laura ^{[1
]}

De Matthaeis, Nicoletta ^{[1
]}

Pizzolante, Fabrizio ^{[1
]}

Gasbarrini, Antonio ^{[1
,2
]}

Zocco, Maria A. ^{[1
,2
]}

Grieco, Antonio ^{[1
,2
]}

Rapaccini, Gianludovico ^{[1
,2
]}

Miele, Luca ^{[1
,2
]}

机构：

[1] Sacred Heart Catholic Univ, IRCCS A Gemelli Univ Polyclin Fdn, Dept Med & Surg Sci, Largo Gemelli 8, I-00168 Rome, Italy

[2] Sacred Heart Catholic Univ, Dept Med & Translat Surg, Rome, Italy

来源：

MINERVA GASTROENTEROLOGY | 2021年 / 67卷 / 02期

关键词：

Non-alcoholic fatty liver disease; Review; Gastroenterology; MAGNETIC-RESONANCE ELASTOGRAPHY; RADIATION FORCE IMPULSE; TRANSIENT ELASTOGRAPHY; STIFFNESS MEASUREMENT; DIAGNOSTIC-ACCURACY; NONINVASIVE TOOLS; FIBROSIS; METAANALYSIS; PERFORMANCE; MANAGEMENT;

D O I：

10.23736/S2724-5985.21.02801-4

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

Non-alcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease worldwide and its prevalence is even higher in patients with risk factors such as type 2 diabetes and obesity. Liver biopsy is the gold standard for diagnosis of non-alcoholic steatohepatitis (NASH), particularly for the assessment of fibrosis stage that is a key prognostic factor. Noninvasive methods for assessment of liver fibrosis are a huge need in contemporary hepatology in order to stratify patient's risk of advanced and progressive liver disease. In this perspective different imaging techniques have been developed in last decades and showed high performance in liver fibrosis evaluation. Strengths and weaknesses of all imaging methods are summarized in this review.

引用

页码：164 / 170

页数：7

共 50 条

[21] Non-alcoholic Fatty Liver Disease
Tan, Hui-Hui
Chang, Jason Pik-Eu
PROCEEDINGS OF SINGAPORE HEALTHCARE, 2010, 19 (01) : 36 - 50
[22] Non-alcoholic fatty liver disease
Angulo, P
Lindor, KD
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2002, 17 : S186 - S190
[23] Non-alcoholic fatty liver disease
Powell, Elizabeth E.
Wong, Vincent Wai-Sun
Rinella, Mary
LANCET, 2021, 397 (10290): : 2212 - 2224
[24] Non-alcoholic fatty liver disease
Carreras, MP
Tortajada, GC
REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2005, 97 (05) : 377 - 377
[25] Non-alcoholic fatty liver disease
Neuschwander-Tetri, Brent A.
BMC MEDICINE, 2017, 15
[26] Non-alcoholic fatty liver disease
Maurice, James
Manousou, Pinelopi
CLINICAL MEDICINE, 2018, 18 (03) : 245 - 250
[27] Non-alcoholic fatty liver disease
Smith, Briohny W.
Adams, Leon A.
CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES, 2011, 48 (03) : 97 - 113
[28] Non-alcoholic fatty liver disease
Tuyama, Ana C.
Chang, Charissa Y.
JOURNAL OF DIABETES, 2012, 4 (03) : 266 - 280
[29] Non-alcoholic fatty liver disease
Bjornsson, Einar
Angulo, Paul
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2007, 42 (09) : 1023 - 1030
[30] Non-alcoholic fatty liver disease
Cua, IHY
George, J
HOSPITAL MEDICINE, 2005, 66 (02): : 106 - 111

← 1 2 3 4 5 →